HillQAStampsRMasseyE, et al.The diagnosis and management of primary autoimmune haemolytic anaemia. Br J Haematol2016; 176: 395–411.
2.
NaderKPatelMFerberA. Ofatumumab in rituximab-refractory autoimmune hemolytic anemia associated with chronic lymphocytic leukemia: a case report and review of literature. Clin Lymphoma Myeloma Leuk2013; 13: 511–513.
3.
MasoudSMcAdooSPBediR, et al.Ofatumumab for B cell depletion in patients with systemic lupus erythematosus who are allergic to rituximab. Rheumatology2018; 57: 1156–1161.
4.
KarageorgasTZomasAKazakouP, et al.Successful treatment of life-threatening autoimmune haemolytic anaemia with ofatumumab in a patient with systemic lupus erythematosus. Rheumatology (Oxford)2016; 55: 2085–2087.
